ORTHOCELL LIMITED - Announcements

Market Cap $75.35M Add to my watchlist

Healthcare Biotechnology

Orthocell Limited is an Australia-based regenerative medicine company. The Company is... Orthocell Limited is an Australia-based regenerative medicine company. The Company is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes Striate+, Remplir, and OrthoACI. Striate+ is a sterile, resorbable collagen membrane used for guided bone and tissue regeneration in dental applications. Remplir is a collagen scaffold used in peripheral nerve repair. OrthoACI or autologous chondrocyte implantation is used for the treatment of articular cartilage defects in the knee and ankle. OrthoACI uses the patient’s own healthy cartilage cells called chondrocytes to assist the regeneration of damaged cartilage. The Company is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

OCC	*Change of Director's Interest Notice 5**		29/01/21	496.57KB	Share
OCC	Novel Surgical Treatment for Tendon Repair		28/01/21	246.41KB	Share
OCC	Appendix 2A		22/01/21	280.01KB	Share
OCC	Orthocell Receives A$2.3m R&D Tax Incentive Refund	PRICE SENSITIVE	20/01/21	191.85KB	Share
OCC	Orthocell Receives First US CelGro Product Approval	PRICE SENSITIVE	14/01/21	232.56KB	Share
OCC	Trading Halt	PRICE SENSITIVE	12/01/21	355.33KB	Share
OCC	Pause in Trading	PRICE SENSITIVE	12/01/21	114.61KB	Share
OCC	Appendix 2A and Notice Under Section 708A		07/01/21	289.13KB	Share
OCC	CelGro Receives Australian Market Approval	PRICE SENSITIVE	23/12/20	187.83KB	Share
OCC	CelGro Completes Pivotal Step in TGA Approval Process	PRICE SENSITIVE	17/12/20	216.12KB	Share
OCC	*Change of Director's Interest Notice 4**		23/11/20	433.84KB	Share
OCC	Positive Results in CelGro Nerve Repair Study	PRICE SENSITIVE	20/11/20	295.9KB	Share
OCC	Trading Halt	PRICE SENSITIVE	18/11/20	212.19KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	29/10/20	930.03KB	Share
OCC	Appendix 3G		27/10/20	297.93KB	Share
OCC	*Change of Director's Interest Notice 5**		20/10/20	462.28KB	Share
OCC	Appendix 3G		15/10/20	300.36KB	Share
OCC	Results of Meeting		14/10/20	137.77KB	Share
OCC	Exercise Price of Options		14/10/20	133.88KB	Share
OCC	Appendix 3G		08/10/20	267.72KB	Share
OCC	Meet the CEO Investor Presentation		22/09/20	135.3KB	Share
OCC	Revised Investor Presentation		18/09/20	11.83MB	Share
OCC	AGM and Director Nomination Dates		18/09/20	152.07KB	Share
OCC	CelGro Bone Regeneration in Dental & Orthopedic Applications	PRICE SENSITIVE	17/09/20	227.62KB	Share
OCC	Investor presentation		15/09/20	11.53MB	Share
OCC	CelGro Reaches 300 Cases Under Special Access Scheme		14/09/20	254.79KB	Share
OCC	Letter to Shareholders - Annual General Meeting		11/09/20	90.2KB	Share
OCC	Notice of Annual General Meeting/Proxy Form		11/09/20	1.66MB	Share
OCC	Appendix 4E and Annual Report to Shareholders	PRICE SENSITIVE	31/08/20	5.84MB	Share
OCC	Appendix 4G		31/08/20	189.6KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	31/07/20	445.39KB	Share
OCC	CelGro Nerve Repair AUS Regulatory Application Submitted	PRICE SENSITIVE	30/07/20	196.63KB	Share
OCC	Appendix 2A and Notice Under Section 708A		16/07/20	288.71KB	Share
OCC	Orthocells Ortho-ATI Shows 87.5% Success Rate	PRICE SENSITIVE	09/07/20	253.93KB	Share
OCC	Recruitment Complete - Ortho-ATI Shoulder Tendon Study		30/06/20	169.54KB	Share
OCC	Change of Director's Interest Notice LW		17/06/20	138.18KB	Share
OCC	Appendix 3G		17/06/20	272.93KB	Share
OCC	Initial Director's Interest Notice LW		10/06/20	152.21KB	Share
OCC	Orthocell Appoints Executive Director Leslie Wise		10/06/20	177.52KB	Share
OCC	CelGro US 510(k) Submission Completed	PRICE SENSITIVE	12/05/20	240.65KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	30/04/20	631.86KB	Share
OCC	Successful Rotator Cuff Regeneration Publication		02/04/20	248.24KB	Share
OCC	Successful CelGro US Bone Repair Study	PRICE SENSITIVE	11/03/20	222.92KB	Share
OCC	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/20	1.07MB	Share
OCC	Appendix 2A and Notice Under Section 708A		19/02/20	282.13KB	Share
OCC	Initial Director's Interest Notice MC		11/02/20	174.87KB	Share
OCC	Orthocell Board Update		11/02/20	161.04KB	Share
OCC	Orthocell receives new patents for CelGro		05/02/20	187.97KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	31/01/20	660.57KB	Share
OCC	Orthocell receives A$2.9m R&D tax incentive refund		15/01/20	184.81KB	Share
OCC	Appendix 3B - SPP		30/12/19	389.39KB	Share
OCC	Share Purchase Plan Update		27/12/19	180.93KB	Share
OCC	Appendix 2A and Notice Under Section 708A		17/12/19	285.12KB	Share
OCC	US Nerve Repair Study Design Meets FDA Requirements	PRICE SENSITIVE	16/12/19	253.02KB	Share
OCC	Placement Completion		11/12/19	193.24KB	Share
OCC	Appendix 3B and Notice Under Section 708A		11/12/19	396.67KB	Share
OCC	SPP Offer Document and Terms And Conditions	PRICE SENSITIVE	05/12/19	704.9KB	Share
OCC	Notice Under ASIC Corporations Instrument 2019/547		05/12/19	194.99KB	Share
OCC	Placement and Share Purchase Plan	PRICE SENSITIVE	04/12/19	265.55KB	Share
OCC	Trading Halt	PRICE SENSITIVE	02/12/19	368.63KB	Share
OCC	Change of Director's Interest Notice LL Amended		22/11/19	198.4KB	Share
OCC	Change of Director's Interest Notice PA		22/11/19	195.99KB	Share
OCC	Change of Director's Interest Notice LL		22/11/19	198.39KB	Share
OCC	Appendix 3B		20/11/19	818.51KB	Share
OCC	Results of Meeting		20/11/19	197.55KB	Share
OCC	Exercise Price of Options		20/11/19	450.35KB	Share
OCC	New Collagen Rope Patent for CelGro Platform Technology	PRICE SENSITIVE	12/11/19	685KB	Share
OCC	Appendix 3B and Notice Under Section 708A		07/11/19	357.49KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	31/10/19	871.61KB	Share
OCC	Notice of Annual General Meeting/Proxy Form		18/10/19	1.48MB	Share
OCC	Change of Director's Interest Notice PA		15/10/19	368.76KB	Share
OCC	Appendix 3B and Notice Under Section 708A		10/10/19	826.62KB	Share
OCC	CelGro Nerve Regeneration Results in Quadriplegic Patients	PRICE SENSITIVE	09/10/19	946.99KB	Share
OCC	Trading Halt	PRICE SENSITIVE	07/10/19	326.27KB	Share
OCC	Appendix 3B and Notice Under Section 708A		11/09/19	355.89KB	Share
OCC	Ceasing to be a substantial holder		10/09/19	109.86KB	Share
OCC	OCC presents at H.C. Wainwright Annual Investment Conference		10/09/19	2.56MB	Share
OCC	Successful CelGro Tendon Regeneration Trial	PRICE SENSITIVE	04/09/19	345.26KB	Share
OCC	Appendix 4G		30/08/19	201.14KB	Share
OCC	Appendix 4E and Annual Report to Shareholders	PRICE SENSITIVE	30/08/19	6.03MB	Share
OCC	Final Director's Interest Notice MC		26/08/19	202.51KB	Share
OCC	Change of Management of OCC Shareholding		26/08/19	227.4KB	Share
OCC	Ceasing to be a substantial holder		26/08/19	64.21KB	Share
OCC	Ceasing to be a substantial holder		26/08/19	55.15KB	Share
OCC	Change of Director's Interest Notice MC		26/08/19	149.6KB	Share
OCC	Director Temporary Leave of Absence		23/08/19	962.1KB	Share
OCC	Change of Director's Interest Notice QXZ		23/08/19	285.92KB	Share
OCC	New Patent for CelGro Platform Technology		22/08/19	206.9KB	Share
OCC	Appendix 3B and Notice Under Section 708A		14/08/19	827.8KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	31/07/19	387.26KB	Share
OCC	Appendix 3B and Notice Under Section 708A		25/07/19	357.39KB	Share
OCC	CelGro Study Validates High Quality Nerve Repair	PRICE SENSITIVE	25/07/19	431.48KB	Share
OCC	*Change of Director's Interest Notice 4**		11/07/19	387.97KB	Share
OCC	Appendix 3B and Notice Under Section 708A		11/07/19	357.43KB	Share
OCC	Appendix 3B and Notice Under Section 708A		01/07/19	360.29KB	Share
OCC	CelGro Accelerates Dental Implant Treatments	PRICE SENSITIVE	19/06/19	250.11KB	Share
OCC	Appendix 3B		13/06/19	815.77KB	Share
OCC	Change in substantial holding MHZ		11/06/19	46.98KB	Share
OCC	Change in substantial holding SRV		07/06/19	156.86KB	Share
OCC	Change in substantial holding MC		07/06/19	76.86KB	Share

OCC *Change of Director's Interest Notice 5**
29/01/21		496.57KB	Share
OCC Novel Surgical Treatment for Tendon Repair
28/01/21		246.41KB	Share
OCC Appendix 2A
22/01/21		280.01KB	Share
OCC Orthocell Receives A$2.3m R&D Tax Incentive Refund
20/01/21	PRICE SENSITIVE	191.85KB	Share
OCC Orthocell Receives First US CelGro Product Approval
14/01/21	PRICE SENSITIVE	232.56KB	Share
OCC Trading Halt
12/01/21	PRICE SENSITIVE	355.33KB	Share
OCC Pause in Trading
12/01/21	PRICE SENSITIVE	114.61KB	Share
OCC Appendix 2A and Notice Under Section 708A
07/01/21		289.13KB	Share
OCC CelGro Receives Australian Market Approval
23/12/20	PRICE SENSITIVE	187.83KB	Share
OCC CelGro Completes Pivotal Step in TGA Approval Process
17/12/20	PRICE SENSITIVE	216.12KB	Share
OCC *Change of Director's Interest Notice 4**
23/11/20		433.84KB	Share
OCC Positive Results in CelGro Nerve Repair Study
20/11/20	PRICE SENSITIVE	295.9KB	Share
OCC Trading Halt
18/11/20	PRICE SENSITIVE	212.19KB	Share
OCC Appendix 4C - Quarterly
29/10/20	PRICE SENSITIVE	930.03KB	Share
OCC Appendix 3G
27/10/20		297.93KB	Share
OCC *Change of Director's Interest Notice 5**
20/10/20		462.28KB	Share
OCC Appendix 3G
15/10/20		300.36KB	Share
OCC Results of Meeting
14/10/20		137.77KB	Share
OCC Exercise Price of Options
14/10/20		133.88KB	Share
OCC Appendix 3G
08/10/20		267.72KB	Share
OCC Meet the CEO Investor Presentation
22/09/20		135.3KB	Share
OCC Revised Investor Presentation
18/09/20		11.83MB	Share
OCC AGM and Director Nomination Dates
18/09/20		152.07KB	Share
OCC CelGro Bone Regeneration in Dental & Orthopedic Applications
17/09/20	PRICE SENSITIVE	227.62KB	Share
OCC Investor presentation
15/09/20		11.53MB	Share
OCC CelGro Reaches 300 Cases Under Special Access Scheme
14/09/20		254.79KB	Share
OCC Letter to Shareholders - Annual General Meeting
11/09/20		90.2KB	Share
OCC Notice of Annual General Meeting/Proxy Form
11/09/20		1.66MB	Share
OCC Appendix 4E and Annual Report to Shareholders
31/08/20	PRICE SENSITIVE	5.84MB	Share
OCC Appendix 4G
31/08/20		189.6KB	Share
OCC Appendix 4C - Quarterly
31/07/20	PRICE SENSITIVE	445.39KB	Share
OCC CelGro Nerve Repair AUS Regulatory Application Submitted
30/07/20	PRICE SENSITIVE	196.63KB	Share
OCC Appendix 2A and Notice Under Section 708A
16/07/20		288.71KB	Share
OCC Orthocells Ortho-ATI Shows 87.5% Success Rate
09/07/20	PRICE SENSITIVE	253.93KB	Share
OCC Recruitment Complete - Ortho-ATI Shoulder Tendon Study
30/06/20		169.54KB	Share
OCC Change of Director's Interest Notice LW
17/06/20		138.18KB	Share
OCC Appendix 3G
17/06/20		272.93KB	Share
OCC Initial Director's Interest Notice LW
10/06/20		152.21KB	Share
OCC Orthocell Appoints Executive Director Leslie Wise
10/06/20		177.52KB	Share
OCC CelGro US 510(k) Submission Completed
12/05/20	PRICE SENSITIVE	240.65KB	Share
OCC Appendix 4C - Quarterly
30/04/20	PRICE SENSITIVE	631.86KB	Share
OCC Successful Rotator Cuff Regeneration Publication
02/04/20		248.24KB	Share
OCC Successful CelGro US Bone Repair Study
11/03/20	PRICE SENSITIVE	222.92KB	Share
OCC Half Yearly Report and Accounts
25/02/20	PRICE SENSITIVE	1.07MB	Share
OCC Appendix 2A and Notice Under Section 708A
19/02/20		282.13KB	Share
OCC Initial Director's Interest Notice MC
11/02/20		174.87KB	Share
OCC Orthocell Board Update
11/02/20		161.04KB	Share
OCC Orthocell receives new patents for CelGro
05/02/20		187.97KB	Share
OCC Appendix 4C - Quarterly
31/01/20	PRICE SENSITIVE	660.57KB	Share
OCC Orthocell receives A$2.9m R&D tax incentive refund
15/01/20		184.81KB	Share
OCC Appendix 3B - SPP
30/12/19		389.39KB	Share
OCC Share Purchase Plan Update
27/12/19		180.93KB	Share
OCC Appendix 2A and Notice Under Section 708A
17/12/19		285.12KB	Share
OCC US Nerve Repair Study Design Meets FDA Requirements
16/12/19	PRICE SENSITIVE	253.02KB	Share
OCC Placement Completion
11/12/19		193.24KB	Share
OCC Appendix 3B and Notice Under Section 708A
11/12/19		396.67KB	Share
OCC SPP Offer Document and Terms And Conditions
05/12/19	PRICE SENSITIVE	704.9KB	Share
OCC Notice Under ASIC Corporations Instrument 2019/547
05/12/19		194.99KB	Share
OCC Placement and Share Purchase Plan
04/12/19	PRICE SENSITIVE	265.55KB	Share
OCC Trading Halt
02/12/19	PRICE SENSITIVE	368.63KB	Share
OCC Change of Director's Interest Notice LL Amended
22/11/19		198.4KB	Share
OCC Change of Director's Interest Notice PA
22/11/19		195.99KB	Share
OCC Change of Director's Interest Notice LL
22/11/19		198.39KB	Share
OCC Appendix 3B
20/11/19		818.51KB	Share
OCC Results of Meeting
20/11/19		197.55KB	Share
OCC Exercise Price of Options
20/11/19		450.35KB	Share
OCC New Collagen Rope Patent for CelGro Platform Technology
12/11/19	PRICE SENSITIVE	685KB	Share
OCC Appendix 3B and Notice Under Section 708A
07/11/19		357.49KB	Share
OCC Appendix 4C - Quarterly
31/10/19	PRICE SENSITIVE	871.61KB	Share
OCC Notice of Annual General Meeting/Proxy Form
18/10/19		1.48MB	Share
OCC Change of Director's Interest Notice PA
15/10/19		368.76KB	Share
OCC Appendix 3B and Notice Under Section 708A
10/10/19		826.62KB	Share
OCC CelGro Nerve Regeneration Results in Quadriplegic Patients
09/10/19	PRICE SENSITIVE	946.99KB	Share
OCC Trading Halt
07/10/19	PRICE SENSITIVE	326.27KB	Share
OCC Appendix 3B and Notice Under Section 708A
11/09/19		355.89KB	Share
OCC Ceasing to be a substantial holder
10/09/19		109.86KB	Share
OCC OCC presents at H.C. Wainwright Annual Investment Conference
10/09/19		2.56MB	Share
OCC Successful CelGro Tendon Regeneration Trial
04/09/19	PRICE SENSITIVE	345.26KB	Share
OCC Appendix 4G
30/08/19		201.14KB	Share
OCC Appendix 4E and Annual Report to Shareholders
30/08/19	PRICE SENSITIVE	6.03MB	Share
OCC Final Director's Interest Notice MC
26/08/19		202.51KB	Share
OCC Change of Management of OCC Shareholding
26/08/19		227.4KB	Share
OCC Ceasing to be a substantial holder
26/08/19		64.21KB	Share
OCC Ceasing to be a substantial holder
26/08/19		55.15KB	Share
OCC Change of Director's Interest Notice MC
26/08/19		149.6KB	Share
OCC Director Temporary Leave of Absence
23/08/19		962.1KB	Share
OCC Change of Director's Interest Notice QXZ
23/08/19		285.92KB	Share
OCC New Patent for CelGro Platform Technology
22/08/19		206.9KB	Share
OCC Appendix 3B and Notice Under Section 708A
14/08/19		827.8KB	Share
OCC Appendix 4C - Quarterly
31/07/19	PRICE SENSITIVE	387.26KB	Share
OCC Appendix 3B and Notice Under Section 708A
25/07/19		357.39KB	Share
OCC CelGro Study Validates High Quality Nerve Repair
25/07/19	PRICE SENSITIVE	431.48KB	Share
OCC *Change of Director's Interest Notice 4**
11/07/19		387.97KB	Share
OCC Appendix 3B and Notice Under Section 708A
11/07/19		357.43KB	Share
OCC Appendix 3B and Notice Under Section 708A
01/07/19		360.29KB	Share
OCC CelGro Accelerates Dental Implant Treatments
19/06/19	PRICE SENSITIVE	250.11KB	Share
OCC Appendix 3B
13/06/19		815.77KB	Share
OCC Change in substantial holding MHZ
11/06/19		46.98KB	Share
OCC Change in substantial holding SRV
07/06/19		156.86KB	Share
OCC Change in substantial holding MC
07/06/19		76.86KB	Share

REFRESH

First 2 3 4 5

(20min delay)
Last 36.0¢		Change 0.010(2.86%)		Mkt cap ! $75.35M

Open	High	Low	Value	Volume
35.0¢	36.0¢	35.0¢	$38.21K	107.6K

Buyers (Bids)

No.	Vol.	Price($)
3	51713	35.5¢

Sellers (Offers)

Price($)	Vol.	No.
36.0¢	68224	2

View Market Depth

No.	Vol.	Price($)
3	51713	0.355
6	89024	0.350
2	10000	0.345
5	44823	0.340
3	99128	0.335

Price($)	Vol.	No.
0.360	68224	2
0.365	8221	1
0.370	26000	2
0.375	20000	1
0.380	250009	3

Last trade - 12.59pm 06/06/2024 (20 minute delay)


Last 36.0¢		Change 0.010 ( 1.41 %)
Open	High	Low	Volume
35.0¢	36.0¢	35.0¢	74628
Last updated 14.36pm 06/06/2024 ?

OCC (ASX) Chart

ORTHOCELL LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available